Home > Boards > US Listed > Biotechs >

Intellia Therapeutics Inc. (NTLA)

NTLA RSS Feed
Add NTLA Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 11/25/2020 2:59:16 PM - Followers: 12 - Board type: Free - Posts Today: 0

Intellia Therapeutics, Inc. is a United States-based genome editing company focused on the development of curative therapeutics using a biological tool, CRISPR/Cas9 system. The Company's CRISPR/Cas9 technology edits diseased genes in the human body through a single treatment course. It focuses on the therapeutic applications of CRISPR/Cas9 genome editing. Its portfolio includes CRISPR/Cas9 platform technology, delivery technologies and nucleic acid modifications for human therapeutic use. The Company's CRISPR/Cas9 platform components include the guide ribonucleic acid (RNA) and the Cas9 nuclease (the genetic scissors). It has access to various delivery modalities specific to various in vivo and ex vivo approaches. The Company focuses on engineering ex vivo CRISPR/Cas9 cell therapies for chimeric antigen receptor T cell (CAR-T) and hematopoietic stem cell (HSC) applications. It also focuses on the use of in vivo Lipid Nanoparticle (LNP) delivery technology.
NTLA
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NTLA News: Current Report Filing (8-k) 11/09/2020 07:55:11 AM
NTLA News: Intellia Therapeutics Doses First Patient in Landmark CRISPR/Cas9 Clinical Trial of NTLA-2001 for the Treatment of Transthyre... 11/09/2020 07:30:00 AM
NTLA News: Statement of Changes in Beneficial Ownership (4) 11/06/2020 04:40:10 PM
NTLA News: Quarterly Report (10-q) 11/05/2020 09:02:34 AM
NTLA News: Current Report Filing (8-k) 11/05/2020 07:56:39 AM
PostSubject
#10   Arsenal Bio [1] is also using it for jondoeuk 11/25/20 02:59:16 PM
#9   Currently, the company is using CRISPR/Cas9 screening to jondoeuk 11/25/20 02:58:37 PM
#8   Preclinical data (at ASH) https://ashpublications.org/blood/article/136/Suppleme jondoeuk 11/04/20 06:06:01 PM
#7   Bought more at $18.30 before selling all @ chmcnfunds 01/08/18 01:50:15 PM
#6   CRISPR hits a snag: Our immune systems may chmcnfunds 01/08/18 10:57:51 AM
#5   In at $18.90. Got to believe the drop chmcnfunds 01/08/18 10:56:50 AM
#4   I don't have enough understanding on how the rule_rationale 10/09/17 01:19:13 PM
#3   Am I the only one that thinks this jimski55 10/06/17 03:38:42 PM
#2   Which of the big three is closest to redspinelpinktopaz 03/07/17 02:18:43 PM
#1   Took a starter here, CRISPR could do amazing things! rule_rationale 05/10/16 11:00:34 AM
PostSubject
Consent Preferences